in fact, among those who do start using GLP-1s, over 50% stop due to costs, and as many as 36% stop due to side effects
Consistent with these findings, an updated meta-analysis of thirteen phase 2 and phase 3 RCTs (n = 1,811 participants) showed that GLP-1RAs, especially semaglutide 2.4 mg weekly, significantly reduce hepatic fat content, promote MASH resolution, and improve liver fibrosis in patients with MASH, regardless of T2DM status (Mantovani et al., 2025[42])
As melanin synthesis decreases, the skin appears lighter, more radiant, and even toned
The 2 mg starting dose functions the same way, giving your GI tract and metabolic receptors time to adapt before the dose increases
Yes, sufficient Vitamin B12 levels during pregnancy reduce risks of complications like neural tube defects and support fetal development.